Matthew P. Pando
Chief Executive Officer at Recognify Life Sciences, Inc.
Matthew P. Pando active positions
| Companies | Position | Start | End |
|---|---|---|---|
Recognify Life Sciences, Inc.
 Recognify Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Recognify Life Sciences, Inc. develops treatments for cognitive impairment associated with schizophrenia. The company is based in Brisbane, CA. The company was founded by Thomas C. Südhof, Matthew P. Pando, Kristen Angela MacFarlane, Gary Walker. Matthew P. Pando has been the CEO since incorporation. | Chief Executive Officer | - | - |
| Founder | - | - | |
| President | - | - | |
Boost Neuroscience, Inc.
 Boost Neuroscience, Inc. Miscellaneous Commercial ServicesCommercial Services Boost Neuroscience, Inc. is an American company that focuses on researching and developing therapies for age-related cognitive deficits. The CEO of the company is Matthew P. Pando. | Chief Executive Officer | - | - |
| Director of Finance/CFO | - | - |
Career history of Matthew P. Pando
Former positions of Matthew P. Pando
| Companies | Position | Start | End |
|---|---|---|---|
Exonhit
 Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Chief Tech/Sci/R&D Officer | 2010-07-18 | 2012-12-19 |
| Corporate Officer/Principal | 2010-07-18 | 2010-07-18 | |
| EUROBIO SCIENTIFIC | Chief Tech/Sci/R&D Officer | 2008-03-31 | - |
Training of Matthew P. Pando
| Colorado State University | Undergraduate Degree |
| The Salk Institute for Biological Studies | Doctorate Degree |
| University of California San Diego | Doctorate Degree |
Statistics
International
| United States | 6 |
| France | 3 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 2 |
| Chief Executive Officer | 2 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 3 |
| Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| EUROBIO SCIENTIFIC | Health Technology |
| Private companies | 3 |
|---|---|
Exonhit
Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Health Technology |
Recognify Life Sciences, Inc.
Recognify Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Recognify Life Sciences, Inc. develops treatments for cognitive impairment associated with schizophrenia. The company is based in Brisbane, CA. The company was founded by Thomas C. Südhof, Matthew P. Pando, Kristen Angela MacFarlane, Gary Walker. Matthew P. Pando has been the CEO since incorporation. | Commercial Services |
Boost Neuroscience, Inc.
Boost Neuroscience, Inc. Miscellaneous Commercial ServicesCommercial Services Boost Neuroscience, Inc. is an American company that focuses on researching and developing therapies for age-related cognitive deficits. The CEO of the company is Matthew P. Pando. | Commercial Services |
- Stock Market
- Insiders
- Matthew P. Pando
- Experience
